IV Antibiotics for Pyelonephritis

First-Line IV Antibiotic Options

The European Association of Urology recommends fluoroquinolones (ciprofloxacin 400mg IV twice daily or levofloxacin 750mg IV once daily), extended-spectrum cephalosporins (ceftriaxone 1-2g IV daily or cefepime 1-2g IV twice daily), or aminoglycosides (gentamicin 5mg/kg IV once daily) as first-line options for hospitalized patients with pyelonephritis requiring IV therapy, with selection based on local resistance patterns and patient-specific factors 1, 2
Ciprofloxacin 400mg IV twice daily is a recommended fluoroquinolone option 1, 2
Levofloxacin 750mg IV once daily is a recommended fluoroquinolone option, offering convenient once-daily dosing 1, 2, 3
Fluoroquinolones should only be used empirically if local fluoroquinolone resistance is ≤10% 4
Ceftriaxone 1-2g IV once daily is a recommended extended-spectrum cephalosporin option, with a higher 2g dose recommended despite lower doses being studied 1, 2
Gentamicin 5mg/kg IV once daily is a recommended aminoglycoside option, which should be combined with ampicillin when used empirically 1, 2, 4

The European Association of Urology recommends reserving carbapenems and novel broad-spectrum agents exclusively for patients with early culture results indicating multidrug-resistant organisms 1, 2
Imipenem/cilastatin 0.5g IV three times daily is a recommended carbapenem option 1, 2
Meropenem 1g IV three times daily is a recommended carbapenem option 1, 2

Urine culture with antimicrobial susceptibility testing is mandatory in all pyelonephritis cases, according to the European Association of Urology 1, 2, 4
If local fluoroquinolone resistance >10%, avoid empiric fluoroquinolone monotherapy, and use an extended-spectrum cephalosporin or aminoglycoside instead 1, 2, 4
For uncomplicated pyelonephritis in areas with low fluoroquinolone resistance (<10%): ciprofloxacin 400mg IV twice daily or levofloxacin 750mg IV once daily are recommended options 1, 2, 3
For uncomplicated pyelonephritis in areas with high fluoroquinolone resistance (>10%): ceftriaxone 2g IV once daily or cefepime 2g IV twice daily are recommended options 1, 2

The European Association of Urology recommends a treatment duration of 5-7 days for fluoroquinolones 4
Trimethoprim-sulfamethoxazole should be used for 14 days 4
β-lactams should be used for 10-14 days 4

The European Association of Urology recommends monitoring elderly patients closely for adverse effects, particularly aminoglycosides (nephrotoxicity and ototoxicity) and fluoroquinolones (CNS effects and tendinopathy) 3

Failing to obtain urine cultures before starting antibiotics prevents targeted therapy adjustment, according to the European Association of Urology 4
Using fluoroquinolones empirically in areas with >10% resistance without adding an initial parenteral agent is not recommended 4
Using oral β-lactams as monotherapy without an initial parenteral dose is associated with treatment failure 4
Not considering local resistance patterns when selecting empiric therapy is a common pitfall 1, 2, 4